<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35586153</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2451-9936</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>American journal of ophthalmology case reports</Title>
          <ISOAbbreviation>Am J Ophthalmol Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sclerouveitis with exudative retinal detachment associated with chronic myelomonocytic leukemia.</ArticleTitle>
        <Pagination>
          <StartPage>101573</StartPage>
          <MedlinePgn>101573</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">101573</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajoc.2022.101573</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">To describe a case of sclerouveitis with exudative retinal detachment in a patient with chronic myelomonocytic leukemia.</AbstractText>
          <AbstractText Label="OBSERVATIONS" NlmCategory="UNASSIGNED">An 82-year-old woman with chronic myelomonocytic leukemia (CMML) presented with acute painful right eye redness and decreased visual acuity. Examination revealed right eye anterior and posterior scleritis with exudative retinal detachment, as well as 2+ anterior chamber cell in the right eye and 0.5+ in the left eye. Workup was negative for infectious etiologies and chest imaging revealed no pulmonary nodules. She was treated with prednisolone drops and a tapering course of oral prednisone as she started therapy with ruxolitinib for CMML. Inflammation resolved with treatment, and she remained quiet off steroids while on ruxolitinib.</AbstractText>
          <AbstractText Label="CONCLUSIONS AND IMPORTANCE" NlmCategory="UNASSIGNED">This is the first case report to specifically describe sclerouveitis associated with CMML, despite the known association of this cancer with various inflammatory manifestations. This case demonstrates that CMML may present with scleritis and uveitis, and should be considered as the underlying etiology of inflammatory eye disease in patients with a diagnosis of CMML.</AbstractText>
          <CopyrightInformation>© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nachbor</LastName>
            <ForeName>Kristine M</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Minkus</LastName>
            <ForeName>Caroline L</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Am J Ophthalmol Case Rep</MedlineTA>
        <NlmUniqueID>101679941</NlmUniqueID>
        <ISSNLinking>2451-9936</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chronic myelomonocytic leukemia</Keyword>
        <Keyword MajorTopicYN="N">Eye inflammation</Keyword>
        <Keyword MajorTopicYN="N">Masquerade</Keyword>
        <Keyword MajorTopicYN="N">Scleritis</Keyword>
        <Keyword MajorTopicYN="N">Uveitis</Keyword>
      </KeywordList>
      <CoiStatement>No funding or grant support. The following authors have no financial disclosures: KMN, CLM. All authors attest that they meet the current ICMJE criteria for Authorship. No acknowledgements.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>2</Hour>
          <Minute>19</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35586153</ArticleId>
        <ArticleId IdType="pmc">PMC9108460</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ajoc.2022.101573</ArticleId>
        <ArticleId IdType="pii">S2451-9936(22)00319-X</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Patnaik M.M., Tefferi A. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management. Am J Hematol. Jan 2020;95(1):97–115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31736132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coltro G., Patnaik M.M. Chronic myelomonocytic leukemia: insights into biology, prognostic factors, and treatment. Curr Oncol Rep. Nov 2019;21(11):101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31728739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guru Murthy G.S., Dhakal I., Mehta P. Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States. Leuk Lymphoma. Jul 2017;58(7):1648–1654.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27881041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benzarti S., Daskalakis M., Feller A., et al.  Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: a comparison between Swiss and American population-based cancer registries. Cancer Epidemiol. Apr 2019;59:51–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30690330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rollison D.E., Howlader N., Smith M.T., et al.  Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SSER programs. Blood. Jul 2008;112(1):45–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18443215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zahid M.F., Barraco D., Tasho T.L., et al.  Spectrum of autoimmune disease and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia. Leuk Lymphoma. Jun 2017;58(6):1488–1493.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27739921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peker D., Padron E., Bennett J.M., et al.  A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution. Acta Haematol. 2015;133(2):249–256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25413011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mekinian A., Grignano E., Braun T., et al.  Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology. 2016;55:291–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26350487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wijetunga J.G., Mitchell T.R., Black P.D. Chronic myelomonocytic leukemia presenting as a keratouveitis. Ann Ophthalmol. May 1986;18(5):199–200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3459388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malecha M.A., Holland E.J. Peripheral keratitis associated with chronic myelomonocytic leukemia. Cornea. 2002;21(7):723–724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12352095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaikh A., Parulekar M., James B. Acute suprachoroidal haemorrhage with acute angle closure glaucoma as a presenting sign of chronic myelomonocytic leukemia. Eye. Sep 2002;16(5):651–653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12194088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García Fernández M., Moreno C.J. Arteritic anterior ischemic optic neuropathy associated with chronic myelomonocytic leukemia (CMML): a case report. Vis Pan-Am. 2014;13(4):121–123.</Citation>
        </Reference>
        <Reference>
          <Citation>De Smit E., O'Sullivan E. A diagnostic challenge: chronic myelomonocytic leukaemia and recurrent anterior ischaemic optic neuropathy. Int Ophthalmol. Aug 2013;33(4):415–423.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23179230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolff-Kormann P.G., Hasenfratz B.C., Heinrich B., Kormann B. Successful treatment with hydroxyurea of ocular involvement in chronic myelomonocytic leukemia. N Engl J Med. Jul 1991;325(3):209–210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2052066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Head J.E., Shen D., Santiago-Maysonet M., Bishop R.J., Chan C.C. Ocular pathology of uncommon hematologic malignancies: a case series. J Med Case Rep. Nov 2007;1:158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2211492</ArticleId>
            <ArticleId IdType="pubmed">18045486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serratrice J., Granel B., Swiader L., et al.  Sarcoidosis preceding chronic myelomonocytic leukemia. Dermatology. 2002;205:409–412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12444342</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
